FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 160 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $100,000 | +156.4% | 2,650 | +14.7% | 0.00% | +100.0% |
| Q4 2020 | $39,000 | +200.0% | 2,310 | -17.2% | 0.00% | +100.0% |
| Q3 2020 | $13,000 | -23.5% | 2,790 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $17,000 | +183.3% | 2,790 | 0.0% | 0.00% | – |
| Q1 2020 | $6,000 | -53.8% | 2,790 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $13,000 | +18.2% | 2,790 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $11,000 | -35.3% | 2,790 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $17,000 | -54.1% | 2,790 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $37,000 | +42.3% | 2,790 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $26,000 | -33.3% | 2,790 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $39,000 | -11.4% | 2,790 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $44,000 | +10.0% | 2,790 | +19.7% | 0.00% | 0.0% |
| Q1 2018 | $40,000 | -21.6% | 2,330 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $51,000 | -35.4% | 2,330 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $79,000 | +12.9% | 2,330 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $70,000 | -16.7% | 2,330 | 0.0% | 0.00% | -25.0% |
| Q1 2017 | $84,000 | – | 2,330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|